| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.28T | 2.13T | 1.85T | 1.73T | 1.50T | 1.49T |
| Gross Profit | 438.66B | 431.54B | 312.24B | 333.82B | 256.58B | 191.16B |
| EBITDA | 245.69B | 214.33B | 117.88B | 157.46B | 106.66B | 55.95B |
| Net Income | 109.69B | 88.00B | 25.38B | 53.03B | 21.80B | -19.33B |
Balance Sheet | ||||||
| Total Assets | 3.29T | 3.02T | 2.68T | 2.46T | 2.17T | 1.96T |
| Cash, Cash Equivalents and Short-Term Investments | 108.75B | 132.78B | 84.15B | 138.42B | 108.51B | 126.70B |
| Total Debt | 1.05T | 889.51B | 845.23B | 785.26B | 666.84B | 593.35B |
| Total Liabilities | 2.41T | 2.29T | 2.03T | 1.86T | 1.65T | 1.48T |
| Stockholders Equity | 807.69B | 702.91B | 634.09B | 576.20B | 505.48B | 465.33B |
Cash Flow | ||||||
| Free Cash Flow | 46.94B | 50.26B | -48.40B | -35.33B | 97.95B | -17.09B |
| Operating Cash Flow | 146.54B | 148.94B | 31.66B | 23.62B | 156.89B | 34.60B |
| Investing Cash Flow | -127.76B | -111.20B | -89.81B | -77.46B | -58.40B | -37.39B |
| Financing Cash Flow | -42.85B | 9.61B | 12.91B | 85.31B | -108.90B | 23.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥1.43T | 20.64 | 12.13% | 1.21% | 4.63% | 12.32% | |
69 Neutral | ¥2.57T | 18.60 | 10.09% | 0.97% | 5.35% | 26.51% | |
67 Neutral | ¥3.54T | 25.09 | 23.30% | 0.71% | -1.66% | 19.02% | |
66 Neutral | ¥2.33T | 13.24 | 16.00% | 1.38% | 13.96% | 12.97% | |
64 Neutral | ¥2.81T | 9.91 | 14.59% | 1.40% | 14.12% | 54.64% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥636.53B | 18.29 | 4.83% | 2.95% | -2.67% | -85.21% |